| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13G · 5 securities · passive | ||||||
|
PAVmed Inc.
13G/A
PAVM · 70387R502
|
15.3% |
4/14/2026
Event 3/27/2026
|
||||
| Tasso Partners, LLC | 14.3% | |||||
| Dana Carrera | 15.3% | |||||
|
Orchestra BioMed Holdings, Inc.
13G
OBIO · 68572M106
|
5.5% |
11/19/2025
Event 11/15/2025
|
||||
| Tasso Partners, LLC | 5.0% | |||||
| Dana Lorenzo | 5.5% | |||||
|
DarioHealth Corp.
13G/A
DRIO · 23725P209
|
10.0% |
11/12/2025
Event 9/30/2025
|
||||
| Tasso Partners, LLC | 10.0% | |||||
| Dana Carrera | 10.0% | |||||
|
Super League Enterprise, Inc.
13G/A
SLE · 86804F301
|
5.7% |
5/15/2025
Event 3/31/2025
|
||||
| Tasso Partners, LLC | 5.1% | |||||
| Dana Carrera | 5.7% | |||||
|
PAVmed Inc.
13G
PAVM · 70387R403
|
18.9% |
2/28/2025
Event 2/21/2025
|
||||
| Tasso Partners, LLC | 18.9% | |||||
| Dana Carrera | 18.9% | |||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.